Cialis doing more then expected
April 19, 2007

NEW YORK : Lilly reported Sales of erectile dysfunction drug Cialis and bipolar disorder and schizophrenia drug Zyprexa both are gaining more his expectations.

He reported its paper results after the Monday. Its $508.7 million profit was 39 percent lesser than its year-ago total and this was due to its takeover of ICOS Corp. and a restructuring charge. After excluding those expenses, his earnings came to 84 cents per share.

Robert Hazlett analyst of 'BMO Capital Markets' said that company's prices and sales amount both has augmented. According to him sales of Cialis, diabetes drug Byetta and depression treatment Cymbalta will continue to climb over the next few years.

Also they are expecting this type of solid Results till the end of year 2007.

All these thing raise the Lilly's share from 47 cents to & 58.87 and will climb to %59.00 As it is excepted